:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/22002075/4de5a643ef00fe7ff172b10b084c2c6e_wm.png)
Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients.
Summary: For patients with Type 2 diabetes, managing weight is often just as important as managing blood sugar. Unfortunately, some types of insulin can cause unwanted weight gain. A study comparing two common long-acting insulins—Insulin Detemir and NPH Insulin—found that Detemir has a distinct advantage.
Researchers discovered that patients using Detemir lost an average of 0.8 kg (about 1.7 lbs) compared to when they used NPH. The reason? It appears to be related to how the kidneys handle salt and water. Detemir seems to encourage the kidneys to flush out slightly more sodium and fluid, particularly in the first week of treatment. This "water weight" reduction explains why patients on Detemir often maintain a lower weight than those on NPH, offering a helpful bonus for diabetic heart and kidney health.